: AbbVie to buy Cerevel Therapeutics in $8.7 billion all-cash deal
<p>AbbVie Inc. said late Wednesday it has agreed to buy Cerevel Therapeutics Holdings Inc. for $8.7 billion, saying that Cerevel’s “robust” neuroscience pipeline adds medications that may transform standards of care in psychiatric and neurological illnesses. Read Full Story</p>
<p>The post <a href="https://forextv.com/market-news/abbvie-to-buy-cerevel-therapeutics-in-8-7-billion-all-cash-deal/">: AbbVie to buy Cerevel Therapeutics in $8.7 billion all-cash deal</a> appeared first on <a href="https://forextv.com">ForexTV</a>.</p>
Leave a Comment